(Q42627139)

English

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study

scientific article published on 2 December 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

Antonio D'Avolio

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

S Bonora

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Calcagno

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

C Cometto

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

S Fontana

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

D Aguilar

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

D Gonzalez de Requena

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Maiello

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

I Dal Conte

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Lucchini

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

G Di Perri

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

2 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

69-75

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Late diagnosis of HIV in Europe: definitional and public health challenges

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Early mortality and cause of deaths in patients using HAART in Brazil and the United States

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Association between specific enfuvirtide resistance mutations and CD4 cell response during enfuvirtide-based therapy

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Efficacy and Safety of Maraviroc Versus Efavirenz, Both With Zidovudine/Lamivudine: 96-Week Results From the MERIT Study

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Immunological and virological study of enfuvirtide-treated HIV-positive patients

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

1 reference

https://api.crossref.org/works/10.1007%2FS15010-011-0223-4

21 January 2018

Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22135137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S15010-011-0223-4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42627139&oldid=2205555120"